dr. reddy's labs glp-1 receptor agonist weight management diabetes treatments Laboratories has entered the fast-growing therapy segment with the launch of its semaglutide generic, Obeda, for Type 2 in India's โน1,446 crore market. ๐๐๐๐ ๐๐ฎ๐ฅ๐ฅ ๐๐ซ๐ญ๐ข๐๐ฅ๐ ๐จ๐ง ๐จ๐ฎ๐ซ Dr. Reddy's Laboratories Launches Obeda:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 31 - Nov 5














:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)








